| 15 May, 04:46 pm | — | … | Gland Pharma Ltd - 543245 - Corporate Action-Board approves Dividend | bse |
| 15 May, 04:42 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 May, 04:38 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 15 May, 04:35 pm | — | … | Gland Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 15 May, 04:32 pm | — | … | Gland Pharma Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Q4FY26 Audited Financial results". | nse |
| 15 May, 04:25 pm | — | … | Gland Pharma Ltd - 543245 - Q4FY26 Audited Financial Results | bse |
| 15 May, 04:20 pm | — | … | Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting - 15052026 | bse |
| 15 May, 04:20 pm | — | … | Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 14 May, 06:33 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 14 May, 06:32 pm | — | … | Gland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 12 May, 05:20 pm | — | … | Gland Pharma Limited has informed the Exchange regarding 'Intimation of ESOP Compensation Committee Meeting'. | nse |
| 30 Apr, 01:09 pm | — | … | Gland Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 27 Apr, 02:26 pm | — | … | Gland Pharma Limited has informed the Exchange regarding 'Clarification with respect to Announcement made on 13th April , 2026, regarding Postal Ballot Notice'. | nse |
| 21 Apr, 05:06 pm | — | … | Gland Pharma Ltd - 543245 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 And To Consider And Recommend Payment Of Final Dividend, If Any For The Financial Year Ended March 31, 2026 | bse |
| 09 Apr, 07:12 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 09 Apr, 07:08 pm | — | … | Gland Pharma Ltd - 543245 - Board Meeting Outcome for Reappointment Of Ms. Naina Lal Kidwai As An Independent Director, Subject To Shareholders Approval | bse |
| 09 Apr, 07:07 pm | — | … | Gland Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on April 09, 2026. | nse |
| 06 Apr, 12:15 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 06 Apr, 12:14 pm | — | … | Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Prasadha rao Lysetti as Other of the company w.e.f. April 06, 2026. | nse |
| 06 Mar, 04:01 pm | — | … | Gland Pharma Ltd - 543245 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 06 Mar, 04:01 pm | — | … | Gland Pharma Limited has informed the Exchange about Order passed by the GST Authority | nse |
| 04 Mar, 11:06 am | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Mar, 11:04 am | — | … | Gland Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Gland Pharma Receives Tentative Approval for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC)". | nse |
| 03 Mar, 07:10 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) | bse |
| 03 Mar, 07:09 pm | — | … | Gland Pharma Limited has informed the Exchange regarding Resignation of Mr Shyamakant Giri as Chief Executive Officer of the company w.e.f. April 30, 2026. | nse |
| 03 Mar, 06:52 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Issue of Securities | bse |
| 03 Mar, 06:52 pm | — | … | Gland Pharma Limited has informed the Exchange about Options to purchase securities | nse |
| 18 Feb, 12:11 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 18 Feb, 12:06 pm | — | … | Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Jitendra Gangwal as Other of the company w.e.f. February 18, 2026. | nse |
| 06 Feb, 11:13 am | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Feb, 11:11 am | — | … | Gland Pharma Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Gland Pharma Receives Approval for Zoledronic Acid Injection, 4 mg/100 mL (0.04 mg/ mL) Single-Dose Bags". | nse |
| 03 Feb, 05:03 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 03 Feb, 05:02 pm | — | … | Gland Pharma Limited has informed the Exchange about Transcript | nse |
| 29 Jan, 04:13 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 29 Jan, 04:12 pm | — | … | Gland Pharma Limited has informed the Exchange about change in Management | nse |
| 28 Jan, 09:16 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 28 Jan, 09:15 pm | — | … | Gland Pharma Limited has informed the Exchange about Link of Recording | nse |
| 28 Jan, 05:28 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 28 Jan, 05:27 pm | — | … | Gland Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 28 Jan, 05:23 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Jan, 05:23 pm | — | … | Gland Pharma Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "UFR Q3FY26". | nse |
| 28 Jan, 05:18 pm | — | … | Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting Held On January 28, 2026 | bse |
| 28 Jan, 05:14 pm | — | … | Gland Pharma Ltd - 543245 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025 | bse |
| 28 Jan, 05:10 pm | — | … | Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 09 Jan, 12:24 pm | — | … | Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025 | bse |
| 07 Jan, 03:41 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Jan, 03:40 pm | — | … | Gland Pharma Limited has informed the Exchange regarding a press release dated January 07, 2026, titled "Gland Pharma receives approval from the United States Food and Drug Administration (USFDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)". | nse |
| 07 Nov, 04:42 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 07 Nov, 04:41 pm | — | … | Gland Pharma Limited has informed the Exchange about Transcript | nse |
| 03 Nov, 09:24 pm | — | … | Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |